Clinical Trials in Arizona

Showing 15401-15420 of 16,770 trials

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

NCT00432458

RATIONALE: Zoledronate may prevent bone loss and stop the growth of cancer cells in bone. Thalidomide may stop the growth of cancer cells by blocking blood flow to the cancer. It is not yet know whether giving zoledronate together with thalidomide is more effective than zoledronate alone in treating multiple myeloma. PURPOSE: This randomized phase III trial is studying zoledronate and thalidomide see how well they work compared with zoledronate alone in treating patients with early stage multiple myeloma.

Multiple Myeloma and Plasma Cell Neoplasm

Mayo Clinic68 participantsStarted Jul 2003

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States +1 more locations

COMPLETEDPhase 331 miles

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

NCT00257205

This is a Phase 3, multi-national, open-label, 2-arm randomized study in patients with surgically incurable metastatic melanoma who have received no prior chemotherapy, or biochemotherapy for the treatment of metastatic disease. The primary objective of this trial is to compare overall survival for patients with advanced melanoma who are randomized to receive CP-675,206 with that of patients who are randomized to receive either dacarbazine or temozolomide (investigator choice)

Melanoma

AstraZeneca655 participantsStarted Mar 2006

Huntsville, Alabama, United States • Mobile, Alabama, United States • Scottsdale, Arizona, United States +140 more locations

Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

Find Trials by Condition in Arizona

Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1%

Peripheral Facilitated Antegrade Steering Technique in Chronic Total Occlusions

An Open-label, Multi-center Study Evaluating the Validity, Reliability, and Responsiveness of a New Female-specific Angina Questionnaire in Women With Chronic Angina Treated With Ranolazine Extended-release Tablets (CVT 3041)

Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

ADX10059 as an add-on Therapy to Proton Pump Inhibitors (PPIs) in Patients With Gastroesophageal Reflux (GERD)

Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer

Study of Epratuzumab in Systemic Lupus Erythematosus

Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

A Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

CRESTOR Athero Imaging Head to Head IVUS Study

Study Of SU011248 Versus Chemotherapy For Patients With Previously Treated Triple Receptor Negative Breast Cancer

Lopinavir/Ritonavir (Kaletra) PK in Children

Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System

A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus

Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Comparison Study for Safety and Efficacy of Two Devices for the Treatment of the Great Saphenous Vein

Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Combination With Paclitaxel and Carboplatin in Patients With Advanced or Metastatic Solid Tumors